LAURA INGRAHAM (HOST): The medical establishment has completely dismissed a drug that doctors all over the world are now successfully using to treat COVID patients. It's not just hydroxychloroquine, but dozens of therapeutics that are far safer than a vaccine that we still don't know a lot about. Is that true?
Well, joining me now is Dr. Peter McCullough, internist and cardiologist. He's been spearheading efforts to get this countervailing perspective in front of Congress. Dr. McCullough, you say that — we call it the medical establishment, big med — are engaging in what you call “therapeutic nihilism." Explain that.
DR. PETER MCCULLOUGH (GUEST): Well Laura, thanks for having me on the show. And let me say my opinions are my own and not necessarily those of my institution. But boy, November 19 and today, December 8, two big days, Ron Johnson in the Senate subcommittee hearings, important information for Americans. And what we've learned is that there has been a prevailing view of therapeutic nihilism, where nothing can be done for COVID- 19.
But what we've learned is what we call sequential multi-drug treatment for early COVID-19 in patients at risk over age 50 or with medical problems, with three layers of medicines: anti-infectives, corticosteroids, and then and antithrombotics, or blood thinners, has a marked improvement in outcomes, can reduce hospitalizations by 85%, cut mortality in half.
INGRAHAM: Well, and I think we know now, and looking at the language, that in order to get emergency-use authorization for these vaccines, it can't be that there are safe therapeutics that show effectiveness against this particular virus. That's one of the requirements for the emergency use provision. So you couldn't have hydroxychloroquine working, or ivermectin, or steroids, or a combination, correct?
MCCULLOUGH: Well, EUA is really not needed for available drugs that can be used in appropriate off-label use. So it turns out that ivermectin, hydroxychloroquine, we heard today about favipiravir, which I think, honestly, we should have brought into the United States very early on. It's used in Russia, India, China, as a direct oral antiviral. But one of those three drugs paired with doxycycline azithromycin, that covers that anti-infective layer. We —
INGRAHAM: Right, but what we are saying — what we're saying, Dr. McCullough, is that there was a campaign, a concerted campaign to vilify and dismiss and demean, and, frankly, lie about the effectiveness of these drugs. There's nothing else to call it.
MCCULLOUGH: Well, I mean, Laura, to be honest, if you go back in history, this is not uncommon in pandemics. There's such fear, there's such anxiety. There's a few people who stepped to the front and are real leaders. And what we heard today, we had six leaders who have innovated with their protocols, and they presented them, from Milwaukee, from Florida. They're clearly keeping people out of the hospital. There's many that stepped to the side, and then there's some that are always in the back that are detractors. And what has happened is there are some detractors in medicine —
MCCULLOUGH: — that are coming on board, patients are being treated. The American Association Physicians and Surgeons has a patient guide that's available, that supports doctors in treating patients. And if doctors are uncomfortable in working with these medicines, now there's telemedicine networks that will step in and treat —
INGRAHAM: Yeah, you still have pharmacies and pharmacy boards threatening, being threatened, doctors not allowed to prescribe or being hassled for prescribing certain of these antivirals or therapeutics.